<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03899038</url>
  </required_header>
  <id_info>
    <org_study_id>US-Spinal</org_study_id>
    <nct_id>NCT03899038</nct_id>
  </id_info>
  <brief_title>Minimum Effective Dose of 0.5% Bupivacaine for Ultrasound-guided Spinal Anesthesia Using Taylor's Approach</brief_title>
  <acronym>MEDBST</acronym>
  <official_title>Minimum Effective Dose of 0.5% Bupivacaine for Ultrasound-guided Spinal Anesthesia Using Taylor's Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine the minimum effective dose of bupivacaine 0.5% in 90% of
      patients undergoing lower limb surgery with ultrasound-guided spinal anesthesia using
      Taylor's approach. A biased coin design up-and-down sequential method is applied. The initial
      dose is 15 mg of bupivacaine 0.5%. After 45 successful spinal anesthesia, the ED90 of
      bupivacaine 0.5% will be calculated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The minimum effective dose of local anesthetics for spinal anesthesia using Taylor's approach
      is not known. This study aims to determine the minimum effective dose of bupivacaine 0.5%
      using a biased coin design up-and-down sequential method. Patients will receive real-time
      ultrasound guided spinal anesthesia using Taylor's approach. The initial dose is chosen as 15
      mg on the basis of clinical experience. Subsequently, if a patient has an inadequate block,
      the bupivacaine dose is increased by 2 mg in the next subject. If a patient has a successful
      block, the next subject is randomized to receive either a lower dose (with a decrement of 2
      mg), with a probability of b = 0.11, or the same dose, with a probability of 1 - b = 0.89.
      Forty five successful blocks will be accomplished. MED90 will be calculated by isotonic
      regression.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 8, 2019</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 9, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The minimum effective dose of bupivacaine in spinal anesthesia using Taylor's approach</measure>
    <time_frame>up to 6 months</time_frame>
    <description>The minimum effective dose of bupivacaine in spinal anesthesia using Taylor's approach is based on 45 successful spinal anesthesia performed in patients undergoing lower limb surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the upper level of the sensory block 25 min after bupivacaine injection</measure>
    <time_frame>25 min</time_frame>
    <description>the upper level of the sensory block 25 min after bupivacaine injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of hypotension</measure>
    <time_frame>during anethesia and operation</time_frame>
    <description>the incidence of hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the duration of sensory spinal anaesthesia for the lower extremity</measure>
    <time_frame>up to 3 days postoperation</time_frame>
    <description>the duration of sensory spinal anaesthesia for the lower extremity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative neurological complications</measure>
    <time_frame>up to 3 months postoperation</time_frame>
    <description>postoperative neurological complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Lower Limb Surgery</condition>
  <arm_group>
    <arm_group_label>Deceasing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spinal anesthesia with decreasing dose. Real-time ultrasound-guided spinal anesthesia Using Taylor's approach.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Similar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spinal anesthesia with similar dose. Real-time ultrasound-guided spinal anesthesia Using Taylor's approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spinal anesthesia</intervention_name>
    <description>Patients will receive real-time ultrasound guided spinal anesthesia using Taylor's approach. Various doses of bupivacaine 0.5% (Bupivacaine hydrochloride injection, Harvest Pharmaceutical CO., LTD., Shanghai, China) will be administered.</description>
    <arm_group_label>Deceasing</arm_group_label>
    <arm_group_label>Similar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical statusⅠ- Ⅲ

          -  Lower limb surgery, expected operation time within 2 hours

        Exclusion Criteria:

          -  Patient refusal

          -  American Society of Anesthesiologists physical status IV/V

          -  Peripheral neuropathy

          -  skin infection at the site of injection

          -  allergy to bupivacaine or lidocaine

          -  BMI &gt; 35 kg/m2

          -  coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mujun Chang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tongji Hospital,Wuhan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>September 14, 2019</last_update_submitted>
  <last_update_submitted_qc>September 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Wei Mei</investigator_full_name>
    <investigator_title>Vice Director, Department of Anaesthesiology, Tongji Hospital of Tongji Medical College</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

